Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes
Sponsor: Massachusetts General Hospital
A PHASE2 clinical study on Autoimmune Diabetes and Covid19, this trial is ongoing. The trial is conducted by Massachusetts General Hospital and has accumulated 13 data snapshots since 2015. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
13 versions recorded-
Jan 2026 — Present [monthly]
Active Not Recruiting PHASE2
-
Jul 2025 — Jan 2026 [monthly]
Active Not Recruiting PHASE2
-
Sep 2024 — Jul 2025 [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
▶ Show 8 earlier versions
-
Apr 2023 — Jun 2024 [monthly]
Active Not Recruiting PHASE2
-
Jul 2022 — Apr 2023 [monthly]
Active Not Recruiting PHASE2
-
Sep 2021 — Jul 2022 [monthly]
Active Not Recruiting PHASE2
-
Feb 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Recruiting PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Jun 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Massachusetts General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .